
Help Charity Navigator rate more organizations with your tax-deductible donation.
Health : Diseases, Disorders, and Disciplines (Grantmaking/Grants Payable)
Board Leadership
Joe Li
Chair
CEO
Elyse Gellerman
Chief Executive Officer
|
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers. To achieve rapid discovery of cures, the NET Research Foundation directs its donations to fund breakthrough scientific research of neuroendocrine cancers. Since its inception, the NET Research Foundation has awarded over $18 million in large-scale, multi-year research grants to leading scientists at renowned research institutions.
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers. To achieve rapid discovery of cures, the NET Research Foundation directs its donations to fund breakthrough scientific research of neuroendocrine cancers. Since its inception, the NET Research Foundation has awarded over $18 million in large-scale, multi-year research grants to leading scientists at renowned research institutions.
97.50
96.00
Program Expenses (Percent of the charity's total expenses spent on the programs and services it delivers) |
91.6% | |
Administrative Expenses | 3.7% | |
Fundraising Expenses | 4.6% | |
Fundraising Efficiency | $0.07 | |
Working Capital Ratio (years) | 1.63 | |
Program Expenses Growth | 82.8% | |
Liabilities to Assets | 35.2% |
Charity Name & State | Overall Score | Overall Rating |
---|---|---|
Neuroendocrine Tumor Research Foundation (MA) | 96.66 | |
National Comprehensive Cancer Network (PA) | 87.95 | |
Leukemia Research Foundation (IL) | 86.64 | |
GO2 Foundation for Lung Cancer (CA) | 92.92 | |
The Leukemia & Lymphoma Society (NY) | 87.11 |
REVENUE | |
Contributions | |
Contributions, Gifts & Grants | $4,207,348 |
Federated Campaigns | $0 |
Membership Dues | $0 |
Fundraising Events | $0 |
Related Organizations | $0 |
Government Grants | $0 |
Total Contributions | $4,207,348 |
Program Service Revenue | $0 |
Total Primary Revenue | $4,207,348 |
Other Revenue | $402,052 |
TOTAL REVENUE | $4,609,400 |
EXPENSES | |
Program Expenses | $5,244,034 |
Administrative Expenses | $185,715 |
Fundraising Expenses | $255,878 |
TOTAL FUNCTIONAL EXPENSES | $5,685,627 |
Payments to Affiliates | $0 |
Excess (or Deficit) for the year | $-1,076,227 |
Net Assets | $12,349,129 |
Program names and associated costs are listed for the top programs as reported on the charity's most recently filed Form 990. The top programs displayed will include the largest three programs, or those programs covering at least 60% of the charity's total expenses, whichever comes first.
Program Name | Amount Spent | % of Program Expenses |
---|---|---|
Funding Research | $4,797,227 | 91.5% |
Neuroendocrine Tumor Patient Educational Conferences | $335,180 | 6.4% |
Outreach | $111,627 | 2.1% |
Form 990 FYE | Date Published | Overall Score | Overall Rating | ||||||
---|---|---|---|---|---|---|---|---|---|
CN 2.1 | |||||||||
2018-12 | 11/01/2019 | 96.66 | |||||||
2017-12 | 12/01/2018 | 97.17 | |||||||
2016-12 | 09/01/2017 | 92.31 | |||||||
2015-12 | 03/01/2017 | 90.87 | |||||||
2014-12 | 06/01/2016 | 92.92 | |||||||
CN 2.0 | |||||||||
2014-12 | 03/01/2016 | 97.39 | |||||||
2013-12 | 08/01/2015 | 87.64 | |||||||
2012-12 | 12/22/2014 | 93.42 | |||||||
2012-12 | 04/01/2014 | 89.19 | |||||||
2011-12 | 03/01/2013 | 85.77 | |||||||
2010-12 | 10/01/2012 | 92.66 |
The data displayed on this tab is provided by the IRS in the form of Publication 78 and the Business Master File (BMF).
EIN | 20-1945347 |
Name in IRS Master File | NEUROENDOCRINE TUMOR RESEARCH FOUNDATION |
NTEE Code | G12 |
NTEE Classification | Fund Raising and/or Fund Distribution |
NTEE Type | Diseases, Disorders, Medical Disciplines |
Classification | Charitable Organization |
Subsection | 501(c)(3) (View the list of codes) |
Activities | |
Foundation Status | Organization which receives a substantial part of its support from a governmental unit or the general public 170(b)(1)(A)(vi) |
Deductibility | Contributions are deductible |
Affiliation | Independent - the organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations). |
Group Name | [Not Applicable] |
Ruling Date | March, 2005 |
Filing Requirement | 990 (all other) or 990EZ return |
Fiscal Year End | December |
IRS Forms 990 (provided courtesy of Foundation Center) |
(Log In or Register Now to View Forms 990!)
|
Compensation | % of Expenses | Paid to | Title | |
---|---|---|---|---|
$174,190 | 3.06% | Elyse Gellerman | Chief Executive Officer |
Charity Name & State | Overall Score | Overall Rating |
---|---|---|
Neuroendocrine Tumor Research Foundation (MA) | 96.66 | |
Skin Cancer Foundation (NY) | 88.61 | |
Cancer Wellness Center (IL) | 86.46 | |
National Ovarian Cancer Coalition (TX) | 86.00 | |
Commonweal (CA) | 96.66 |
This charity has an official representative registered with Charity Navigator.
Neuroendocrine Tumor Research Foundation
321 Columbus Avenue, Suite 5R
Boston,
MA 02116
tel: (617) 946-1780
EIN: 20-1945347
Joe Li
Chair
Elyse Gellerman
Chief Executive Officer
Charity Navigator
299 Market Street Suite 250
Saddle Brook, NJ 07663
EIN: 13-4148824
BRIDGE ID: 3108588923